On July 12, 2017, Jonathan Silverstein notified Audentes Therapeutics, Inc. of his decision to resign from the company’s Board of Directors effective as of the same date. Additionally, on July 12, 2017, Thomas Woiwode notified the company of his decision to resign from the company’s Board of Directors effective as of the same date. Neither resignation was due to any disagreement with the company.